OCEA Ocean Biomedical, Inc.

Fundamentals / CIK 0001869974 / USD

Ocean Biomedical, Inc. reported $1.58M in total assets and a net loss of $30.72M through December 31, 2024 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OCEA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2022 to 2024), reported in USD.

$0$0$0-$107.0MFY 2022 Net Income: -$17.36M2022FY 2023 Net Income: -$114.5M2023FY 2024 Net Income: -$9.48M2024

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $26K $709K $8.41M
Total Operating Expenses $3.80M $10.21M $16.12M
Operating Income -$3.80M -$10.21M -$16.12M
Interest Income -- -- $1.52M
Interest Expense -- $50K $691
Net Income -$9.48M -$114.5M -$17.36M
Basic EPS -$0.34 -$4.35 -$0.74
Diluted EPS -$0.34 -$4.35 -$0.74
Basic Shares Outstanding 27.5M 26.3M 23.4M
Diluted Shares Outstanding 27.5M 26.3M 23.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Research & Development $18K $0 $0 $0 $26K -$17K $305K $28K
Total Operating Expenses $958K $1.75M $768K $682K $595K -$660K $2.65M $2.83M
Operating Income -$958K -$1.75M -$768K -$682K -$595K $660K -$2.65M -$2.83M
Interest Expense $343K -- -- -- $637K $13K $0 $24K
Net Income -$8.24M -$1.54M -$3.70M -$17.23M $13.00M -$16.86M -$14.09M -$11.43M
Basic EPS -$0.09 -- -$0.13 -$0.63 $0.48 -- -$0.53 -$0.43
Diluted EPS -$0.09 -- -$0.13 -$0.63 $0.48 -- -$0.53 -$0.43
Basic Shares Outstanding 91.0M -- 27.5M 27.5M 27.3M -- 26.6M 26.5M
Diluted Shares Outstanding 91.0M -- 27.5M 27.5M 27.3M -- 26.6M 26.5M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents -- $4.0K $34K $0
Cash & Short-Term Investments -- $4.0K $34K $0
Total Current Assets $812K $2.11M $1.84M $1.55M
Total Non-Current Assets $90K $3.39M $0 $107.1M
Total Assets $902K $5.50M $1.84M $108.7M
Accounts Payable $15.90M $16.18M $11.44M $34K
Short-Term Debt -- $3.20M -- --
Total Current Liabilities $33.89M $30.01M $12.66M $246K
Total Non-Current Liabilities $64.63M $66.25M $0 $3.15M
Total Liabilities $98.52M $96.26M $12.66M $3.40M
Total Debt (incl. Leases) -- $3.20M -- --
Retained Earnings -$205.5M -$196.1M -$81.59M -$564K
Total Stockholders' Equity -$97.62M -$90.76M -$10.82M -$6.66M
Total Equity -$97.62M -$90.76M -$10.82M -$6.66M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Cash & Cash Equivalents -- -- -- $4.0K $19K $4.0K $31K --
Cash & Short-Term Investments -- -- -- $4.0K $19K $4.0K $31K --
Total Current Assets $1.49M $812K $1.04M $1.28M $1.80M $2.11M $1.03M $2.16M
Total Non-Current Assets $90K $90K $90K $574K $1.15M $3.39M $0 $18.76M
Total Assets $1.58M $902K $1.13M $1.85M $2.95M $5.50M $1.03M $20.92M
Accounts Payable $16.39M $15.90M $16.57M $17.18M $16.88M $16.18M $16.05M $14.04M
Short-Term Debt -- -- -- -- -- $3.20M -- --
Total Current Liabilities $26.57M $33.89M $31.82M $30.74M $30.11M $30.01M $30.85M $26.68M
Total Non-Current Liabilities $67.41M $64.63M $65.57M $63.86M $48.62M $66.25M $45.40M $2.64M
Total Liabilities $93.98M $98.52M $97.39M $94.59M $78.73M $96.26M $76.25M $29.32M
Total Debt (incl. Leases) -- -- -- -- -- $3.20M -- --
Retained Earnings -$213.8M -$205.5M -$204.0M -$200.3M -$183.1M -$196.1M -$179.2M -$162.0M
Total Stockholders' Equity -$92.40M -$97.62M -$96.26M -$92.74M -$75.78M -$90.76M -$75.22M -$61.66M
Total Equity -$92.40M -$97.62M -$96.26M -$92.74M -$75.78M -$90.76M -$75.22M -$61.66M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$9.48M -$114.5M -$17.36M
Stock-Based Compensation $745K $1.21M $12.38M
Change in Payables -- -- $290K
Operating Cash Flow -$4.18M -$9.43M -$993K
Purchases of Investments -- -- -$2.10M
Investing Cash Flow -- -- -$2.10M
Common Stock Issued -- $14.26M --
Financing Cash Flow $3.40M $10.40M $967K
Net Change in Cash -$780K $970K -$26K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Net Income -$8.24M -$1.54M -$3.70M -$17.23M $13.00M -$16.86M -$14.09M -$11.43M
Stock-Based Compensation $186K $186K $186K $187K $186K $187K $186K $186K
Operating Cash Flow -$356K -$2.45M -$957K -$290K -$485K -$866K -$1.13M -$4.78M
Common Stock Issued -- -- -- -- -- $0 $0 $0
Financing Cash Flow $909K -- -- -- -- $839K $0 $6.64M
Net Change in Cash $553K -$16K $11K -$290K -$485K -$27K -$1.13M $1.85M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Assets (ROA) -1051.0% -2080.8% -942.4%
Current Ratio 0.02x 0.07x 0.15x
Quick Ratio -- 0.00x 0.00x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Return on Assets (ROA) -1941.8% -1051.0% -2190.4% -1900.5% -997.1% -2080.8% -9562.9% -421.5%
Current Ratio 0.06x 0.02x 0.03x 0.04x 0.06x 0.07x 0.03x 0.08x
Quick Ratio -- -- -- 0.00x 0.00x 0.00x 0.00x --
Operating Income Growth (YoY) -- -365.6% -- -- -- -- -- --
Net Income Growth (YoY) -163.4% -- -- -- -- -- -- --
EPS Growth (YoY) -118.8% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001869974) · from September 30, 2021 Data through March 31, 2025 · synced Nov 21, 2026, 05:16 UTC · Open in terminal